CardioMag Imaging
Stage
Grant - III | DeadTotal Raised
$600KLast Raised
$100KAbout CardioMag Imaging
CardioMag Imaging (CMI) is a medical device company that is engaged in the development and commercialization of a kind of cardiac diagnostic device known as MagnetoCardioGraphs (MCG). The device the company has developed consists of the integration of highly sophisticated sensors, electronics, and software. The company's MCG system is a non-invasive cardiac medical diagnostic device that aims to provide clinically relevant information about heart function without use of ionizing radiation. CardioMag's MCG system is a MCG system to obtain FDA approval.
Loading...
Loading...
CardioMag Imaging Patents
CardioMag Imaging has filed 6 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/30/2015 | 5/23/2017 | Cardiac arrhythmia, Heart diseases, Syndromes affecting the heart, Machine learning, Cardiac electrophysiology | Grant |
Application Date | 10/30/2015 |
|---|---|
Grant Date | 5/23/2017 |
Title | |
Related Topics | Cardiac arrhythmia, Heart diseases, Syndromes affecting the heart, Machine learning, Cardiac electrophysiology |
Status | Grant |
CardioMag Imaging Frequently Asked Questions (FAQ)
Where is CardioMag Imaging's headquarters?
CardioMag Imaging's headquarters is located at 13 British American Blvd, Latham.
What is CardioMag Imaging's latest funding round?
CardioMag Imaging's latest funding round is Grant - III.
How much did CardioMag Imaging raise?
CardioMag Imaging raised a total of $600K.
Who are the investors of CardioMag Imaging?
Investors of CardioMag Imaging include National Institutes of Health, National Science Foundation, Empire State Development and NYSTAR.
Who are CardioMag Imaging's competitors?
Competitors of CardioMag Imaging include Genetesis, Ultrasound Medical Devices, Osprey Medical, Cardiac Science Corporation, Infrascan and 7 more.
Loading...
Compare CardioMag Imaging to Competitors
Intellirod Spine is a company focused on the development of medical technology in the healthcare sector. The company's main offerings include a wireless implantable microelectronic spinal rod strain sensor system, which provides spine surgeons with objective data on rod strain to assess postoperative fusion progress. The company primarily sells to the healthcare industry, specifically to spine surgeons. It was founded in 2003 and is based in Akron, Ohio.
Perseus Medical Technologies is an early-stage medical device company that is providing a portable endoscopic visualization solution for physicians
El-Vision develops the OcuTest device, an "all-in-one" system, for vision examination. The OcuTest is based on smart integration of electro-opto-mechanical components, managed by software, integrating many ophthalmic diagnostics technologies into a single, compact device. Resembling virtual reality goggles, the device is mounted on the head of the subject and performs an automated interactive set of visual functions measurements. The results are registered on an integrated Electronic Medical Records (EMR) system.
NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.
Celerus Diagnostics is aiming to enhance the diagnostic capabilities of the pathology laboratory. Celerus' Rapid IHC technology aims to provide the capability to decentralize testing, and move results closer to the patient for real time decision making.
HyperMed Imaging is a company focused on medical hyperspectral imaging within the healthcare industry. The company's main offering is advanced portable imaging technology that assesses oxyhemoglobin, deoxyhemoglobin, and oxyhemoglobin saturation in superficial tissue, providing key information for various healthcare applications. The primary sector HyperMed Imaging serves is the healthcare industry, specifically in areas requiring quick and efficient determination of surface tissue oxygenation. It was founded in 1997 and is based in Memphis, Tennessee.
Loading...